CLIA-waived molecular diagnostic test delivering rapid infectious disease results in approximately 15 minutes. Combines detection of influenza A/B, respiratory syncytial virus, and COVID-19 in a single assay.
Manufactured by
United States
Diasorin is an IVD manufacturer providing automated and consolidated specialty testing solutions for laboratories. The company offers a broad immunodiagnostic solution pairing LIAISON® chemiluminescent technology with consistent and easy-to-use tests, a reliable molecular portfolio with targeted and syndromic options for detecting pathogens in clinical specimens, and multiplexed-based clinical and life science research solutions. Diasorin's solutions optimize laboratory operations by consolidating, automating, and integrating workflows, enabling early diagnostic delivery to impact patient care and outcomes.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen Uni-medica Technology Co., Ltd
China · 2 relevant products
nal von minden GmbH
Germany · 2 relevant products
LifeSign/PBM
United States · 1 relevant product
ProGnosis Biotech S.A.
Greece · 3 relevant products
Biopanda Reagents
United Kingdom · 6 relevant products
Hangzhou Lysun Biotechnology Co.,Ltd
China · 1 relevant product
ZET MEDİKAL TEKSTİL DIŞ TİC.LTD.ŞTİ.
Türkiye · 2 relevant products
POCBio (Nexlab Co., Ltd.)
China · 2 relevant products
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 1 relevant product
Shanghai Chemtron Biotech Co.,Ltd.
China · 2 relevant products
58 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 109 closest product alternatives
Shenzhen Uni-medica Technology Co., Ltd · China
A rapid diagnostic test for nucleic acid detection of influenza A, influenza B, COVID-19, and respiratory syncytial virus.
nal von minden GmbH · Germany
Multiplexed rapid antigen test for simultaneous detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus. Designed for efficient differential diagnosis of respiratory infections.
LifeSign/PBM · United States
A rapid immunoassay for simultaneous detection and differential diagnosis of SARS-CoV-2, influenza type A, and type B antigens from nasal and nasopharyngeal swab specimens. Provides results in 15 minutes with FDA 510(k) clearance and CLIA waiver status.
ProGnosis Biotech S.A. · Greece
Rapid antigen test for simultaneous detection of influenza A & B and COVID-19 using advanced antigen-antibody technology. Delivers fast, reliable results for respiratory infection screening in clinical settings. ELISA and lateral flow formats available for point-of-care and laboratory use.
Biopanda Reagents · United Kingdom
A qualitative lateral flow immunochromatographic assay for detection of SARS-CoV-2, Influenza A+B, Respiratory Syncytial Virus (RSV), Adenovirus, and M. pneumoniae antigens in nasopharyngeal swab samples. This multiplex test assists in the diagnosis of multiple respiratory infections in conjunction with other diagnostic methods.
Hangzhou Lysun Biotechnology Co.,Ltd · China
A rapid self-test kit for detecting antigens of Influenza A, Influenza B, COVID-19, and RSV. Provides quick results for respiratory viral infections.
ZET MEDİKAL TEKSTİL DIŞ TİC.LTD.ŞTİ. · Türkiye
Multiplex lateral flow assay rapid test for simultaneous detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus antigens. Provides comprehensive respiratory pathogen screening.
POCBio (Nexlab Co., Ltd.) · China
A multiplex rapid diagnostic test designed to differentiate between COVID-19, Influenza A, Influenza B, and Respiratory Syncytial Virus (RSV) infections. This test addresses the overlapping symptoms of these respiratory infections and enables rapid differential diagnosis for clinical decision-making.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
Rapid immunochromatographic test for simultaneous detection of COVID-19 and influenza A/B antigens from respiratory specimens. Delivers results in 15-20 minutes, enabling quick differential diagnosis in clinical and point-of-care settings. Single-use test cassette with high sensitivity and specificity for viral antigen identification.
Shanghai Chemtron Biotech Co.,Ltd. · China
A multiplex rapid diagnostic test that simultaneously detects COVID-19, Influenza A and B, respiratory syncytial virus (RSV), and adenovirus (ADV). This combination POCT product enables comprehensive respiratory pathogen screening in a single test.
Hangzhou Fanttest Biotech Co., Ltd. · China
A multiplex antigen test kit that simultaneously detects COVID-19, RSV, and Influenza A&B pathogens. This combo kit enables rapid identification of multiple respiratory infections from a single sample.
DIA.PRO Diagnostic BioProbes Srl · Italy
A CLIA-based diagnostic test for the detection of COVID-19. This assay is designed for clinical laboratory analysis of SARS-CoV-2 infection.
97 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products